ReCyte Therapeutics, Inc. — Form D

ReCyte Therapeutics, Inc. of ALAMEDA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-14. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2011-01-14
• Form: D
• Accession: 0001462573-11-000001
• Industry: Biotechnology
• Exemptions: 06, 46
• Total offering: $2.5M
• Amount sold: $2.5M
• Investors: 2
• Date of first sale: 2010-12-30
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-153749

Issuer

• Name: ReCyte Therapeutics, Inc.
• CIK: 0001509728
• Entity type: Corporation
• Jurisdiction: CALIFORNIA
• Incorporated: 2007
• Address: 1301 HARBOR BAY PARKWAY, SUITE 100, ALAMEDA, CA, 94502
• Phone: (510) 521-3390

Officers, directors & promoters (7)

More

• CIK 1509728 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search